AMSTERDAM — For frontal fibrosing alopecia (FFA), a disease with no approved therapies, topical delgocitinib attenuated inflammation and generated hair regrowth in women in a controlled phase 2a trial. “This is an exciting avenue for FFA if the data are recapitulated in a larger population. It could be an important new treatment option,” said Maryanne Senna, MD,...
Tag: <span>Alopecia</span>
Post
Alopecia Areata: What Happens When Baricitinib Responders Stop Treatment?
Medscape Medical News > MedBrief Deepa Varma August 14, 2024 TOPLINE:Among patients with severe alopecia areata (AA) who have significant hair growth with baricitinib, continuing treatment is needed to maintain hair regrowth, according to the results of a randomized study. METHODOLOGY:Researchers conducted a treatment withdrawal substudy of a randomized, placebo-controlled, phase 3 clinical trial, BRAVE-AA1,...
Post
Study Estimates Post-COVID Risk for Alopecia Areata
Infection with COVID-19 conferred a nearly twofold risk of developing alopecia areata (AA), results from a large analysis of Korean patients demonstrated. “There is a growing number of reports on new onset, exacerbation, and recurrence of AA after COVID-19,” corresponding author Jin Park, MD, PhD, of the Department of dermatology at Jeonbuk National University Medical...
Post
People with alopecia found to have higher risk for inflammatory arthritis
by Lori Solomon Alopecia areata (AA) is associated with a higher risk for inflammatory arthritis, according to a study published online April 28 in the Journal of the American Academy of Dermatology. Colin M. Kincaid, from University of California at Irvine, and colleagues used medical records from 75 health care organizations (TriNetx) to determine if an association exists between...
Post
Stem cell topical solution for baldness offers positive trial results
By Rich Haridy May 18, 2020 South Korean researchers have shown a stem-cell-based topical solution can regrow hair in both male and female subjects with common pattern baldness. The small, randomized, placebo-controlled trial found the treatment both safe and effective, with larger trials hoped to validate the results in more diverse populations. The most common...
Post
Mice with patchy coats lay bare how stem cells endure
Whether we like it or not, our hair continually grows. Its regenerative powers reside deep inside each hair follicle, in a cluster of dividing stem cells—some of which will specialize and eventually give rise to new hair while others will produce new stem cells. Scientists have delineated numerous mechanisms that guide stem cells toward particular...
Post
Platelet-rich plasma injection may be effective for alopecia
(HealthDay)—Subcutaneous injection of platelet-rich plasma (PRP) may be effective for treating alopecia, according to an experimental study published Nov. 11 in the Journal of Cosmetic Dermatology. Sophie Orliac, M.D., from Université Paris Diderot, and colleagues assessed the potential of PRP subcutaneous injection to treat alopecia and to evaluate local toxicity in 12 hairless rats. Subcutaneous injection occurred in...